| 000 | 01847cam a2200349 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030719.0 | ||
| 008 | 121127s2012 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aPh.D | ||
| 099 | _aCai01.11.03.Ph.D.2012.Ra.S | ||
| 100 | 0 | _aRania Elsayed Hussein Abdelrahman | |
| 245 | 1 | 0 |
_aSignaling mechanisms of water soluble curcumin derivative in diabetic cardiovascular complications / _cRania Elsayed Hussein Abdelrahman ; Supervised Mohamed Talaat Abdelaziz , Dimitri Mikhailidis , Ibrahim Elibrashy |
| 246 | 1 | 5 | _aآليات عمل مشتق الكركم القابل للذوبان فى مضاعفات القلب و الأوعية الدموية لمرضى البول السكرى |
| 260 |
_aCairo : _bRania Elsayed Hussein Abdelrahman , _c2012 |
||
| 300 |
_a264 P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of - Medical Biochemistry | ||
| 520 | _aCurcumin has been identified as a potent inducer of heme-oxygenase-1 (HO-1), protein that provides protection against various forms of stress. Diabetic cardiomyopathy characterized by cardiomyocyte hypertrophy, eventually leads to heart failure. Transcriptional co-activator p300 and its interaction with myocyte enhancer factor 2 (MEF2) play a major role in diabetes-induced cardiomyocyte hypertrophy | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCurcumin | |
| 653 | 4 | _aDiabetes type 1 | |
| 653 | 4 | _aDiabetic cardiomyopathy | |
| 700 | 0 |
_aDimitri Mikhailidis , _eSupervisor |
|
| 700 | 0 |
_aIbrahim Elibrashy , _eSupervisor |
|
| 700 | 0 |
_aMohamed Talaat Abdelaziz , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40387 _d40387 |
||